Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Keystone

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Annals of the Rheumatic Diseases|November 25, 2010
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysisCarine Salliot, Axel Finckh, Wanruchada Katchamart, et al.
ACR Open Rheumatology|October 26, 2020
Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal StudyMark R Tatangelo, George Tomlinson, Edward Keystone, et al.
Arthritis Care & Research|August 27, 2016
Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With TocilizumabMuznay N Khawaja, Martin J Bergman, Jeffrey Yourish, et al.
Trials|December 30, 2015
Making smart investment decisions in clinical researchNick Bansback, Edward Keystone, James O'Dell, et al.
The Journal of Rheumatology|November 3, 2016
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
RMD Open|November 30, 2018
ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)Janet E Pope, Mohammad Movahedi, Emmanouil Rampakakis, et al.
Experimental Hematology|August 7, 2003
Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growthAru Narendran, Hooman Ganjavi, Natalie Morson, et al.
Annals of the Rheumatic Diseases|December 18, 2013
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
Arthritis and Rheumatism|October 31, 2009
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritisArthur Kavanaugh, Josef S Smolen, Paul Emery, et al.
Arthritis Care & Research|May 31, 2021
Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four MonthsVivian P Bykerk, Eun Bong Lee, Ronald van Vollenhoven, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|November 25, 2010
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysisCarine Salliot, Axel Finckh, Wanruchada Katchamart, et al.
ACR Open Rheumatology|October 26, 2020
Comorbidities Before and After the Diagnosis of Rheumatoid Arthritis: A Matched Longitudinal StudyMark R Tatangelo, George Tomlinson, Edward Keystone, et al.
Arthritis Care & Research|August 27, 2016
Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With TocilizumabMuznay N Khawaja, Martin J Bergman, Jeffrey Yourish, et al.
Trials|December 30, 2015
Making smart investment decisions in clinical researchNick Bansback, Edward Keystone, James O'Dell, et al.
The Journal of Rheumatology|November 3, 2016
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
RMD Open|November 30, 2018
ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)Janet E Pope, Mohammad Movahedi, Emmanouil Rampakakis, et al.
Experimental Hematology|August 7, 2003
Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growthAru Narendran, Hooman Ganjavi, Natalie Morson, et al.
Annals of the Rheumatic Diseases|December 18, 2013
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
Arthritis and Rheumatism|October 31, 2009
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritisArthur Kavanaugh, Josef S Smolen, Paul Emery, et al.
Arthritis Care & Research|May 31, 2021
Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four MonthsVivian P Bykerk, Eun Bong Lee, Ronald van Vollenhoven, et al.
Pageof 9